Arrest of G1-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription

Molecular and Cellular Biology

Volumn 20, Issue 5, 2000, Pages 1797-1815

  Guardavaccaro, Daniele ^a,b   Corrente, Giuseppina ^a   Covone, Francesca ^a   Micheli, Laura ^a   D'Agnano, Igea ^a   Starace, Giuseppe ^a   Caruso, Maurizia ^a   Tirone, Felice ^a  

^a CNR   (Italy)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN E; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL LEVEL; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; ASPARTIC ENDOPEPTIDASES; CELL CYCLE; CYCLIN D1; G1 PHASE; GENE EXPRESSION REGULATION; MICE; PROPROTEIN CONVERTASES; RETINOBLASTOMA PROTEIN; S PHASE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033976110     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.5.1797-1815.2000     Document Type: Article

References (122)

1. Abken, H., and B. Reifenrath. 1992. A procedure to standardize CAT reporter gene assay. Nucleic Acids Res. 20:3527.
2. Abramovich, C., B. Yakobson, J. Chebath, and M. Revel. 1997. A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I Interferon receptor. EMBO J. 16:260-266.
3. Agarwal, M. L., A. Agarwal, W. R. Taylor, and G. R. Stark. 1995. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad, Sci. USA 92:8493-8497.
4. Agarwal, M. L., W. R. Taylor, M. V. Chernow, O. B. Chernova, and G. R. Stark. 1998. The p53 network. J. Biol. Chem. 273:1-4.
5. Alevizopoulos, K., J. Vlach, S. Hennecke, and B. Amati. 1997. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J. 16:5322-5333.
6. Baker, S. J., S. Markowitz, E. R. Fearon, J. K. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
7. 1. Genes Dev. 7:812-821.
8. Bartek, J., J. Bartkova, and J. Lukas. 1996. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8:805-814.
9. Bradbury, A., R. Possenti, E. M. Shooter, and F. Tirone. 1991. Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc. Natl. Acad. Sci. USA 88: 3353-3357.
10. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
11. Bravo, R., R. Frank, P. A. Blundell, and H. Macdonald-Bravo. 1987. Cyclin/ PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326:515-517.
12. Brugarolas, J., C. Chandrasekaran, J. I. Cordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557.
13. Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105.
14. Caruso, M., F. Martelli, A. Giordano, and A. Felsani. 1993. Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus EIA oncoprotein. Oncogene 8:267-278.
15. Chen, P.-L., D. J. Riley, Y. Chen, and W.-H. Lee. 1996. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10:2794-2804.
16. Chen, P.-L., P. Scully, J.-Y. Shew, J. Y. J. Wang, and W.-H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193-1198.
17. Chen, X., J. Bargonetti, and C. Prives. 1995. p53, through p21 (WAF1/ CIP1), induces cyclin D1 synthesis. Cancer Res. 55:4257-4263.
18. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
19. Connell-trowley, L., J. W. Harper, and D. W. Goodrich. 1997. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8:287-301.
20. Dean, P. N., J. W. Gray, and F. A. Dolbeare. 1982. The analysis and interpretation of DNA distributions measured by flow cytometry. Cytometry 3:188-195.
21. DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C. M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095.
22. Del Sal, G., M. Loda, and M. Pagano. 1996. Cell cycle and cancer: critical events at the G1 restriction point. Crit. Rev. Oncog. 7:127-142.
23. Del Sal, G., M. Murphy, E. Ruaro, D. Lazarevic, A. J. Levine, and C. Schneider. 1996, Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene 12:177-185.
24. Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
25. Desal, D., Y. Gu, and D. O. Morgan. 1992. Activation of human cyclin-dependent kinases in vitro. Mol. Biol. Cell 3:571-582.
26. Diehl, J. A., F. Zindy, and C. J. Sherr. 1997 Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957-972.
27. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
28. Elledge, S. J., R. Richman, F. L. Hall, R. T. Williams, N. Lodgson, and J. W. Harper. 1992. CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. Proc. Natl. Acad. Sci. USA 89:2907-2911.
29. Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74: 1009-1020.
30. Feig, L. A., and G. M. Cooper. 1988. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8:3235-3243.
31. Filmus, J., A. I. Robles, W. Shi, M. J. Wong, L. L. Colombo, and C. J. Conti. 1994. Induction of cyclin D1 overexpression by activated ras. Oncogene 9:3627-3633.
32. Fletcher, B. S., R. W. Lim, B. C. Varnum, D. A. Kujubu, R. A. Koski, and H. R. Herschmati. 1991. Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J. Biol. Chem. 266:14511-14518.
33. Genini, M., P. Schwalbe, F. A. Scholl, A. Remppis, M. G. Mattei, and B. W. Schäfer. 1997. Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol. 16:433-442.
34. Graham, F. L., and A. J. Vander Eb. 1973. A new technique for the assay of infectivity of human adenovirus DNA. Virology 52:456-467.
35. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
36. Greene, L. A. 1978. Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J. Cell Biol. 78:747-755.
37. Greene, L. A., and A. S. Tischler. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73:2424-2428.
38. Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
39. Gu, Y., C. W. Turck, and D. O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710.
40. INK4B/MTS2_related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8:2939-2952.
41. Guardavaccaro, D., A. Montagnoli, M. T. Ciotti, L. Lotti, C. Di Lazzaro, M.-R. Torrisi, A. Gatti, and F. Tirone. 1994. Nerve growth factor regulates the sub-cellular localization of the nerve growth factor-inducible protein PC4 in PC12 cells. J. Neurosci. Res. 37:660-674.
42. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge, 1993. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
43. 1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402-2407.
44. Herwig, S., and M. Strauss. 1997. The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur. J. Biochem. 246: 581-601.
45. Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
46. Holmes, J., and M. J. Solomon. 1996. A predictive scale for evaluating cyclin-dependent kinase substrates. J. Biol. Chem. 271:25240-25246.
47. Iacopetti, P., G. Barsacchi, F. Tirone, L. Maffei, and F. Cremisi. 1994. Developmental expression of PC3 gene is correlated with neuronal cell birthday. Mech. Dev. 47:127-137.
48. Iacopetti, P., M. Michelini, I. Stuckmann, B. Oback, E. Aaku-Saraste, and W. B. Huttner. 1999. Expression of the antiproliferative gene TIS21 at the onset of neurogenesis identifies single neuroepithelial cells that switch from proliferative to neuron-generating division. Proc. Natl. Acad. Sci. USA 96:4639-4644.
49. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993 Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
50. Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massaguè. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260:536-538.
51. Kouzarides, T. 1995. Transcriptional control by the retinoblastoma protein. Semin. Cancer Biol. 6:91-98.
52. LaThangue, N. B. 1994. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell cycle control. Trends Biochem. Sci. 19:108-114.
53. Lee, E. Y.-H. P., C.-Y. Chang, N. Hu, J. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-294.
54. Lee, E. Y.-H. P., N. Hu, S.-S. F. Yuan, L. A. Cox, A. Bradley, W.-H. Lee, and K. Herrup. 1994. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8:2008-2021.
55. Leone, G., J. DeGregori, R. Sears, L. Jakoi, and J. R. Nevins. 1997. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387:422-426.
56. Levine, A. J. 1997. p53. the cellular gatekeeper for growth and division. Cell 88:323-331.
57. Lim, I. K., M. S. Lee, M. S. Ryu, T. J. Park, H. Fujiki, H. Eguchi, and W. K. Paik. 1998. Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21. Mol. Carcinog. 23:25-35.
58. Lin, W. J., J. D. Gary, M. C. Yang, S. Clarke, and H. R. Herschman. 1996 The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J. Biol. Chem. 271:15034-15044.
59. Liu, H. Y., V. Badarinarayana, D. C. Audino, J. Rappsilber, M. Mann, and C. L. Denis. 1998. The NOT proteins are part of the CCR4 transcriptional complex and affect gene expression both positively and negatively. EMBO J. 17:1096-1106.
60. Liu, H. Y., J. H. Toyn, Y. C. Chiang, M. P. Draper, L. H. Johnston, and C. L. Denis. 1997. DBF2, a cell cycle-regulated protein kinase, is physically and functionally associated with the CCR4 transcriptional regulatory complex. EMBO J. 16:5289-5298.
61. Lukas, J., J. Bartkova, M. Rohde, M. Strauss, and J. Bartek. 1995. Cyclin D1 is dispensable for G, control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
62. Lukas, J., T. Herzinger, K. Hansen, M. C. Moroni, D. Resnitzky, K. Helin, S. I. Reed, and J. Bartek. 1997. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11:1479-1492.
63. Lundberg, A. S., and R. A. Weinberg. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753-761.
64. erbB2, is associated with antiproliferative activity. Oncogene 12:705-713.
65. PKSJ3/CDK4) for mammalian D-type G1 cyclins. Cell 71:323-334.
66. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
67. Mesner, P. W., T. R. Winters, and S. H. Green. 1992. NGF withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons. J. Cell Biol. 119:1669-1680.
68. Meyerson, M., G. H. Enders, C.-L. Wu, L.-K. Su, C. Gorka, C. Nelson, E. Harlow, and L.-H. Tsai. 1991. A family of human cdc2-related protein kinases. EMBO J. 11:2909-2917.
69. Meyerson, M., and E. Harlow. 1994. Identification of G, kinase activity for cdk6, a novel cyclin D1 partner. Mol. Cell. Biol. 14:2077-2086.
70. Mittnacht, S. 1998. Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 8:21-27.
71. Mittnacht, S., H. Paterson, M. F. Olson, and C. J. Marshall. 1997. Ras signalling is required for the inactivation of the tumour suppressor pRb cell-cycle control protein. Curr. Biol. 7:219-221.
72. Montagnoli, A., D. Guardavaccaro, G. Starace, and F. Tirone. 1996. Overexpression of the nerve growth factor-inducible PC3 immediate early gene is associated to inhibition of cell proliferation. Cell Growth Differ. 7:1327-1336.
73. Moran, E. 1993. Interaction of adenoviral proteins with pRB and p53. FASEB J. 7:880-885.
74. Morgenbesser, S. D., B. O. Williams, T. Jacks, and R. A. DePinho. 1994. p53-dependent apoptosis produced by Rb-deficicncy in the developing mouse lens. Nature 371:72-74.
75. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587-3596.
76. Müller, H., J. Lukas, A. Schneider, P. Warthoe, J. Bartek, M. Eilers, and M. Strauss. 1994. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc. Natl. Acad. Sci. USA 91:2945-2949.
77. Novitch, B. G., G. J. Mulligan, T. Jacks, and A. B. Lassar. 1996. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135:441-456.
78. Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. F. Draetta. 1992. Cyclin A is required at two points in human cell cycle. EMBO J. 11:961-971.
79. Pagano, M., A. M. Theodoras, S. W. Tam, and G. F. Draetta. 1994. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev. 8:1627-1639.
80. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-liter helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
81. Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio, and M. Ewen. 1997. Ras signalling linked to the cell cycle machinery by the retinoblastoma protein. Nature 386:177-181.
82. cdc2. Cell 58:833-846.
83. Poon, R. Y., H. Toyoshima, and T. Hunter. 1995. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6:1197-1213.
84. Prelich, G., C-K. Tan, M. Kostura, M. B. Mathews, A. G. So, K. M. Downey, and B. Stillman. 1987. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326:517-520.
85. Qin, X.-Q., T. Chittenden, D. Livingston, and W. G. Kaelin. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953-964.
86. Quelle, D. E., R. A. Ashmun, G. J. Hannon, P. A. Rehberger, D. Trono, K. H. Richter, C. Walker, D. Beach, C. J. Sherr, and M. Serrano. 1995. Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene 11:635-645.
87. Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J.-Y. Kato, D. Bar-Sagi, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
88. 1-to-S transition. Mol. Cell. Biol, 15:3463-3469.
89. Reynisdòttir, I., K. Polyak, A. Iavarone, and J. Massaguè. 1995. Kip/Cip and Ink4 Cdk inhibitor cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831-1845.
90. Riabowol, K., G. Draetta, L. Brizuela, D. Vandre, and D. Beach. 1989. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 57:393-401.
91. Riley, D. J., E. Y.-H. P. Lee, and W.-H. Lee. 1994. The retinoblastoma protein: more than a tumor suppressor. Annu. Rev. Cell Biol. 10:1-29.
92. Rouault, J.-P., N. Falette, F. Guéhenneux, C. Guillot, R. Rimokh, Q. Wang, C. Berthet, C. Moyret-Lalle, P. Savatier, B. Pain, P. Shaw, R. Berger, J. Samarut, J.-P. Magaud, M. Ozturk, C. Samarut, and A. Puisieux. 1996. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat. Genet. 14:482-486.
93. Rouault, J.-P., D. Prevot, C. Berthet, A. M. Birot, M. Billaud, J.-P. Magaud, and L. Corbo. 1998. Interaction of BTGI and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex. J. Biol. Chem. 273:22563-22569.
94. Rouault, J.-P., R. Rimokh, C. Tessa, G. Paranhos, M. Ffrench, L. Duret, M. Garoccio, D. Germain, J. Samarut, and J.-P. Magaud. 1992. BTG1, a member of a new family of antiproliferative genes. EMBO J. 11:1663-1670.
95. Kudkin, B. B., P. Lazarovici, B.-Z. Levi, Y. Abe, K. Fujita, and G. Guroff. 1989. Cell cycle-specific action of nerve growth factor in PC12 cells: differentiation without proliferation. EMBO J. 8:3319-3325.
96. Rusconi, S., Y. Severne, O. Georgier, I. Galli, and S. Wieland. 1990. A novel expression assay to study transcriptional activators. Gene 89:211-221.
97. Sanchez, I., and B. D. Dynlacht. 1996. Transcriptional control of the cell cycle. Curr. Opin. Cell Biol. 8:318-324.
98. Schild, D. 1995. Suppression of a new allele of the yeast RAD52 gene by overexpression of RAD51, mutations in srs2 and ccr4, or mating-type heterozygosity. Genetics 140:115-127.
99. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707.
100. 1 arrest checkpoint in response to DNA damage. Mol. Cell. Biol. 18:378-387.
101. Sherr, C. J. 1995. D-type cyclins. Trends Biochem. Sci. 20:187-190.
102. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
103. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
104. Shivji, M. K. K., M. K. Kenny, and R. D. Wood. 1992. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69:367-374.
105. Stamenkovic, I., and B. Seed. 1988. Analysis of two cDNA clones encoding the B lymphocyte antigen CD20 (Bl, Bp35). a type III integral membrane protein. J. Exp. Med. 167:1975-1980.
106. Ink4. Cancer Res. 54:5816-5820.
107. Tam, S. W., A. M. Theodoras, J. W. Shay, G. F. Draetta, and M. Pagano, 1994. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene 9:2663-2674.
108. Tirone, F., and E. M. Shooter. 1989. Early gene regulation by nerve growth factor: induction of an Interferon related gene. Proc. Natl. Acad. Sci. USA 86:2088-2092.
109. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-CDK protein kinase activity, is related to p21. Cell 78:67-74.
110. Van den Heuvel, S., and E. Hallow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054.
111. Vlach, J., S. Hennecke, K. Alevizopoulos, D. Conti, and B. Amati. 1996. Growth arrest by the cyclin-dependent kinase inhibitor p27Kipl is abrogated by c-Myc. EMBO J. 15:6595-6604.
112. Waldman, T., K. W. Kinzler, and B. Vogelstein. 1995. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55:5187-5190.
113. Watanabe, G., C. Albanese, R. J. Lee, A. Reutens, G. Vairo, B. Henglein, and R. G. Pestell. 1998. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Spl. Mol. Cell. Biol. 18:3212-3222.
114. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
115. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases, Nature 366:701-704.
116. Xiong, Y., H. Zhang, and D. Beach. 1992. D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514.
117. Yan, G. Z., and E. B. Ziff. 1997. Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the SP1 transcription factor. J. Neurosci. 17:6122-6132.
118. Yoshida, Y., S. Matsuda, N. Ikematsu, J. Kawamura-Tsuzuku, J. Inazawa, H. Umemori, and T. Yamamoto. 1998. ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system. Oncogene 16:2687-2693.
119. Zacksenhaus, E., Z. Jiang, D. Chung, J. D. Marth, R. A. Phillips, and B. L. Gallie. 1996. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10:3051-3064.
120. Zhan, Q., F. Carrier, and A. J. Fornace, Jr. 1993. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol. 13: 4242-4250.
121. Zhang, H., G. J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750-1758.
122. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111-1125.